Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Moderna has more to offer beyond its Covid vaccine.
The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said.
The update brings Moderna a step closer to having multiple products on the market, which it badly needs amid plunging demand for Covid shots worldwide. The company’s Covid jab is its only commercially available product. Moderna’s stock has long been tied to that vaccine, with shares falling nearly 45% last year.
Moderna will chart its post-Covid future Wednesday during its fifth...